The study, led by graduate research assistant Kombo N’Guessan, PhD, and Xiaoyang Qi, PhD, professor in the Division of Hematology Oncology at the UC College of Medicine, will be published in the June 8 online edition of the journal Molecular Therapy. Read more . . .
As the next step in finding a potential targeted treatment for pancreatic cancer, researchers at the University of Cincinnati are publishing a new study revealing how a combination therapy may improve outcomes for patients with this disease.